Elon Musk is once again pushing back against public claims, this time about drugs. After a recent New York Times article ...

A 56-year-old South Jersey man pleaded guilty to possession of LSD with intent to distribute on Monday, June 16, authorities ...

An international expert panel has developed the first consensus-based framework for reporting ‘set and setting’ variables in ...

Dr. Salvador Plasencia, an urgent care clinic operator in the Los Angeles area, could face up to 40 years in prison in ...

The Central Crime Branch and Avalahalli Police arrested a foreign national in Bangalore for allegedly possessing 600 grams of ...

The investigation into a methylenedioxymethamphetamine (MDMA) drug racket busted by Patamata police has revealed a disturbing ...

The Archetyp Market drug marketplace has been targeted by law enforcement in an operation involving takedowns and arrests.

The most recent congress of the French association of healthcare professionals working in the prison service (ASPEP), held in ...

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with ...

In Sydney, Australia, Rebecca Huntley had been seeking psychiatric care on-and-off for thirty years when she heard from an otherwise straight-edged friend about her experience going through MDMA ...

On Friday, the FDA declined to approve the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news release from drug sponsor Lykos Therapeutics.

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug midomafetamine, also known as MDMA or the street drug ecstasy ...